To achieve a comprehensive and objective evaluation of MHC-I expression in cancers, we developed a MHC-I signature score based on GSVA of eight MHC-I family genes, including HLA-A, HLA-B, HLA-C, HLA-D, HLA-E, HLA-F, HLA-H, and B2M. The gene discussed is B2M; the disease is cancer.